Next Article in Journal
Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies
Next Article in Special Issue
Seroprevalence of Measles Antibodies in the Population of the Olomouc Region, Czech Republic—Comparison of the Results of Four Laboratories
Previous Article in Journal
Does Anybody Want an Injectable Rotavirus Vaccine, and Why? Understanding the Public Health Value Proposition of Next-Generation Rotavirus Vaccines
Previous Article in Special Issue
Reduced Titers of Circulating Anti-SARS-CoV-2 Antibodies and Risk of COVID-19 Infection in Healthcare Workers during the Nine Months after Immunization with the BNT162b2 mRNA Vaccine
 
 
Article

Article Versions Notes

Vaccines 2022, 10(2), 150; https://doi.org/10.3390/vaccines10020150
Action Date Notes Link
article xml file uploaded 20 January 2022 11:22 CET Original file -
article xml uploaded. 20 January 2022 11:22 CET Update https://www.mdpi.com/2076-393X/10/2/150/xml
article pdf uploaded. 20 January 2022 11:22 CET Version of Record https://www.mdpi.com/2076-393X/10/2/150/pdf
article supplementary file uploaded. 20 January 2022 11:22 CET - https://www.mdpi.com/2076-393X/10/2/150#supplementary
article html file updated 20 January 2022 11:23 CET Original file -
article supplementary file uploaded. 20 January 2022 12:12 CET - https://www.mdpi.com/2076-393X/10/2/150#supplementary
article html file updated 20 January 2022 12:13 CET Update -
article html file updated 31 July 2022 04:54 CEST Update https://www.mdpi.com/2076-393X/10/2/150/html
Back to TopTop